Search

everythinglearnresearchcommunity

for

Search:↓

Calculated testosterone values are reliable for assessing hyperandrogenemia in women, making direct measurement unnecessary.

Spironolactone treatment increases the amount of testosterone available in the body.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Metformin is less effective in men with early-onset hair loss.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Zinc and copper levels may affect erectile dysfunction by influencing hormone levels.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Testosterone therapy increases bone density in older men with low testosterone levels.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.